Folate synthesis inhibitor tablets used in combination therapies for toxoplasmosis and uncomplicated malaria. Applied in infectious disease units and pediatric care in affected populations. Obtained by research labs, public sector buyers, and international pharmaceutical networks for synergistic regimens.